Jonathan Feldschuh, Chief Scientific Officer of Daxor Corp ($DXR), made one open market purchase of common shares in the last year, totaling $0, with the most recent on December 9, 2025. This ranks him 4978th among nearly 5,000 insiders in our database by purchase amount, compared to an average of $1.46 million across about 3.3 transactions per insider. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | DAXOR CORP | $DXR | Feldschuh Jonathan Adam | Chief Scientific Officer | P | Daxor Common Stock | 18000 | $0.00 | 53,908.0000 | 4,196,182 | 50.13% | 0.43% |
| Dec. 6, 2024 | DAXOR CORP | $DXR | Feldschuh Jonathan Adam | Chief Scientific Officer | P | Daxor Common Stock | 32000 | $0.00 | 35,908.0000 | 4,196,182 | 818.83% | 0.76% |
| July 11, 2023 | DAXOR CORP | $DXR | Feldschuh Jonathan Adam | Chief Scientific Officer | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 4,196,182 | 9999.99% | 0.60% |